Episode
Episode 60. Emergency Podcast-AQUILA and STARGLO
- Podcast
- Blood Cancer Talks
- Published
- May 28, 2025
- Duration seconds
- 3273
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/bb61526b
Actions
POST https://stenobird.com/v1/public/podcasts/blood-cancer-talks-5570002/episodes/episode-60-emergency-podcast-aquila-and-starglo/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/blood-cancer-talks-5570002/episode-60-emergency-podcast-aquila-and-starglo.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, we discuss the recent proceedings at the FDA ODAC meeting on AQUILA trial in smoldering myeloma and STRAGLO in R/R DLBCL, and provide an update to our audience on some of the clinically relevant data presented from those trials, along with insights from the panelists. Here is the link to the webpage with FDA briefing documents and slides: https://www.fda.gov/advisory-committees/advisory-committee-calendar/may-20-21-2025-meeting-oncologic-drugs-advisory-committee-05202025#event-materials Here is the youtube link for FDA proceedings: https://www.youtube.com/watch?v=5ecyDbK9ezc